Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction Focusing on the Impact on the Quality of Life: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Cureus
; 15(11): e48674, 2023 Nov.
Article
em En
| MEDLINE
| ID: mdl-38090453
entresto; exercise tolerance and heart failure; heart failure and quality of life; heart failure with reduced ejection fraction; heart-related quality of life (hrqol); left ventricular systolic dysfunction; nyha classes ii and iii; sacubitril/valsartan; six-minute walking distance or exercise; systematic review on heart failure with reduced ejection fraction
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Systematic_reviews
Idioma:
En
Revista:
Cureus
Ano de publicação:
2023
Tipo de documento:
Article